Clinical Trial Update: Comparative Pharmacokinetic Study Between Two Extended-Release Cilostazol Formulations in Korea [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic comparison of two extended-release cilostazol formulations conducted in Korea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Cilostazol Extended-Release Formulation A (cilostazol)
• Cilostazol Extended-Release Formulation B (cilostazol)

Snippet

Sponsor: Bundang CHA Hospital | Conditions: Peripheral Artery Disease | Phase 1 | Status: COMPLETED